Skip to main content
NANOVIRICIDES, INC. logo

NANOVIRICIDES, INC. — Investor Relations & Filings

Ticker · NNVC ISIN · US6300873022 LEI · 5493003CK9Y2H0OORR73 US Professional, scientific and technical activities
Filings indexed 536 across all filing types
Latest filing 2007-11-19 Interim / Quarterly Rep…
Country US United States of America
Listing US NNVC

About NANOVIRICIDES, INC.

https://www.nanoviricides.com/

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Recent filings

Filing Released Lang Actions
NANOVIRICIDES, INC. 10QSB 9-30-07
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is a quarterly report filed under the Securities Exchange Act of 1934 for the period ended September 30, 2007. It contains detailed financial statements including balance sheets, statements of operations, cash flows, notes to financial statements, and management's discussion and analysis. The document length is substantial (15,000 characters) and includes unaudited interim financial data and analysis, which is characteristic of an interim or quarterly report. The presence of the term '10-QSB' and the detailed financial content confirms this is a quarterly report filing. Therefore, the document is classified as an Interim / Quarterly Report (IR).
2007-11-19 English
Regulatory Filings 2007
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically references a late filing of a Form 10-Q quarterly report for the period ended September 30, 2007. The document explains the reason for the delay and requests an extension for filing. It does not contain the actual financial statements or substantive financial data of the 10-Q report itself, but rather is a regulatory notification about the late filing. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document and not the report itself.
2007-11-15 English
NANOVIRICIDES 8-K 10-18-2007
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated October 18, 2007, by Nanoviricides, Inc. It reports the consummation of a material definitive agreement involving the sale of common stock and warrants, which is a financing activity. The document includes details about the securities sold, the exemption relied upon for the sale, and exhibits related to subscription agreements and warrants. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The content clearly relates to capital raising and financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 4354 characters, which is sufficient to contain substantive information rather than just an announcement or certification.
2007-10-18 English
NANOVIRICIDES, INC. 10KSB 06-30-07
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB' and is an annual report pursuant to the Securities Exchange Act of 1934 for the fiscal year ended June 30, 2007. It contains detailed sections typical of an annual report, including Description of Business, Risk Factors, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, and Executive Compensation. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is the full annual report filing, not just an announcement or summary. Therefore, this document is classified as an Annual Report (10-K).
2007-10-15 English
Regulatory Filings 2007
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically references a delayed filing of a Form 10-K annual report for the fiscal year ended June 30, 2007. The text explains the reason for the delay and requests an extension for filing. There are no actual financial statements or substantive financial data included in this document; it is purely an announcement regarding the late filing of the 10-K report. According to the 'MENU VS MEAL' rule, such a notification is not the report itself but an announcement related to the report. Therefore, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2007-10-01 English
NANOVIRICIDES 8-K 9-27-2007
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving the sale of shares and warrants, details about the registration rights agreement, and unregistered sales of equity securities. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document is focused on capital raising activities and related agreements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is over 6000 characters, indicating it is a full report rather than a brief announcement or certification.
2007-09-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.